1
|
Dogan H, Norman H, Alrobai A, Jiang N, Nordin N, Adnan A. A Web-Based Intervention for Social Media Addiction Disorder Management in Higher Education: Quantitative Survey Study. J Med Internet Res 2019; 21:e14834. [PMID: 31579018 PMCID: PMC6777277 DOI: 10.2196/14834] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2019] [Revised: 07/13/2019] [Accepted: 07/19/2019] [Indexed: 01/27/2023] Open
Abstract
Background Social media addiction disorder has recently become a major concern and has been reported to have negative impacts on postgraduate studies, particularly addiction to Facebook. Although previous studies have investigated the effects of Facebook addiction disorder in learning settings, there still has been a lack of studies investigating the relationship between online intervention features for Facebook addiction focusing on postgraduate studies. Objective In an attempt to understand this relationship, this study aimed to carry out an investigation on online intervention features for effective management of Facebook addiction in higher education. Methods This study was conducted quantitatively using surveys and partial least square-structural equational modeling. The study involved 200 postgraduates in a Facebook support group for postgraduates. The Bergen Facebook Addiction test was used to assess postgraduates’ Facebook addiction level, whereas online intervention features were used to assess postgraduates’ perceptions of online intervention features for Facebook addiction, which are as follows: (1) self-monitoring features, (2) manual control features, (3) notification features, (4) automatic control features, and (5) reward features. Results The study discovered six Facebook addiction factors (relapse, conflict, salience, tolerance, withdrawal, and mood modification) and five intervention features (notification, auto-control, reward, manual control, and self-monitoring) that could be used in the management of Facebook addiction in postgraduate education. The study also revealed that relapse is the most important factor and mood modification is the least important factor. Furthermore, findings indicated that notification was the most important intervention feature, whereas self-monitoring was the least important feature. Conclusions The study’s findings (addiction factors and intervention features) could assist future developers and educators in the development of online intervention tools for Facebook addiction management in postgraduate education.
Collapse
Affiliation(s)
| | - Helmi Norman
- Faculty of Education, Universiti Kebangsaan Malaysia, Bangi, Malaysia
| | | | - Nan Jiang
- Bournemouth University, Bournemouth, United Kingdom
| | - Norazah Nordin
- Faculty of Education, Universiti Kebangsaan Malaysia, Bangi, Malaysia
| | - Anita Adnan
- Doctorate Support Group, Kuala Lumpur, Malaysia
| |
Collapse
|
2
|
Bergin PS, Brockington A, Jayabal J, Scott S, Litchfield R, Roberts L, Timog J, Beilharz E, Dalziel SR, Jones P, Yates K, Thornton V, Walker EB, Davis S, Te Ao B, Parmar P, Beghi E, Rossetti AO, Feigin V. Status epilepticus in Auckland, New Zealand: Incidence, etiology, and outcomes. Epilepsia 2019; 60:1552-1564. [PMID: 31260104 DOI: 10.1111/epi.16277] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2019] [Revised: 05/18/2019] [Accepted: 06/12/2019] [Indexed: 01/26/2023]
Abstract
OBJECTIVE To determine the incidence, etiology, and outcome of status epilepticus (SE) in Auckland, New Zealand, using the latest International League Against Epilepsy (ILAE) SE semiological classification. METHODS We prospectively identified patients presenting to the public or major private hospitals in Auckland (population = 1.61 million) between April 6, 2015 and April 5, 2016 with a seizure lasting 10 minutes or longer, with retrospective review to confirm completeness of data capture. Information was recorded in the EpiNet database. RESULTS A total of 477 episodes of SE occurred in 367 patients. Fifty-one percent of patients were aged <15 years. SE with prominent motor symptoms comprised 81% of episodes (387/477). Eighty-four episodes (18%) were nonconvulsive SE. Four hundred fifty episodes occurred in 345 patients who were resident in Auckland. The age-adjusted incidence of 10-minute SE episodes and patients was 29.25 (95% confidence interval [CI] = 27.34-31.27) and 22.22 (95% CI = 20.57-23.99)/100 000/year, respectively. SE lasted 30 minutes or longer in 250 (56%) episodes; age-adjusted incidence was 15.95 (95% CI = 14.56-17.45) SE episodes/100 000/year and 12.92 (95% CI = 11.67-14.27) patients/100 000/year. Age-adjusted incidence (10-minute SE) was 25.54 (95% CI = 23.06-28.24) patients/100 000/year for males and 19.07 (95% CI = 16.91-21.46) patients/100 000/year for females. The age-adjusted incidence of 10-minute SE was higher in Māori (29.31 [95% CI = 23.52-37.14]/100 000/year) and Pacific Islanders (26.55 [95% CI = 22.05-31.99]/100 000/year) than in patients of European (19.13 [95% CI = 17.09-21.37]/100 000/year) or Asian/other descent (17.76 [95% CI = 14.73-21.38]/100 000/year). Seventeen of 367 patients in the study died within 30 days of the episode of SE; 30-day mortality was 4.6%. SIGNIFICANCE In this population-based study, incidence and mortality of SE in Auckland lie in the lower range when compared to North America and Europe. For pragmatic reasons, we only included convulsive SE if episodes lasted 10 minutes or longer, although the 2015 ILAE SE classification was otherwise practical and easy to use.
Collapse
Affiliation(s)
- Peter S Bergin
- Auckland District Health Board, Grafton, Auckland, New Zealand.,Centre for Brain Research, University of Auckland, Auckland, New Zealand
| | - Alice Brockington
- Auckland District Health Board, Grafton, Auckland, New Zealand.,Sheffield Teaching Hospitals, NHS Foundation Trust, Sheffield, UK
| | - Jayaganth Jayabal
- Auckland District Health Board, Grafton, Auckland, New Zealand.,Pantai-Gleneagles Hospital, Penang and Sungai Petani, Malaysia
| | - Shona Scott
- Auckland District Health Board, Grafton, Auckland, New Zealand.,Western General Hospital, Edinburgh, UK
| | | | - Lynair Roberts
- Auckland District Health Board, Grafton, Auckland, New Zealand
| | - Jerelyn Timog
- Auckland District Health Board, Grafton, Auckland, New Zealand
| | - Erica Beilharz
- Auckland District Health Board, Grafton, Auckland, New Zealand
| | - Stuart R Dalziel
- Auckland District Health Board, Grafton, Auckland, New Zealand.,Department of Surgery and Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand
| | - Peter Jones
- Auckland District Health Board, Grafton, Auckland, New Zealand
| | - Kim Yates
- Waitematā District Health Board, Auckland, New Zealand
| | | | | | - Suzanne Davis
- Auckland District Health Board, Grafton, Auckland, New Zealand
| | - Braden Te Ao
- National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand
| | - Priya Parmar
- National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand
| | - Ettore Beghi
- Mario Negri Institute of Pharmacological Research, Scientific Institute for Research and Health Care, Milan, Italy
| | - Andrea O Rossetti
- Department of Clinical Neurosciences, Vaud University Hospital Center and University of Lausanne, Lausanne, Switzerland
| | - Valery Feigin
- National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand
| |
Collapse
|
3
|
Bergin PS, Beghi E, Sadleir LG, Tripathi M, Richardson MP, Bianchi E, D'Souza WJ. Do neurologists around the world agree when diagnosing epilepsy? - Results of an international EpiNet study. Epilepsy Res 2017; 139:43-50. [PMID: 29175563 DOI: 10.1016/j.eplepsyres.2017.10.014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2017] [Revised: 04/17/2017] [Accepted: 10/20/2017] [Indexed: 11/30/2022]
Abstract
OBJECTIVE Previous studies have shown moderate agreement between physicians when diagnosing epilepsy, but have included small numbers. The EpiNet study group was established to undertake multicentre clinical trials in epilepsy. Before commencing trials, we wanted to determine levels of agreement between physicians from different countries and different health systems when diagnosing epilepsy, specific seizure types and etiologies. METHODS 30 Case scenarios describing six children and 24 adults with paroxysmal events (21 epileptic seizures, nine non-epileptic attacks) were presented to physicians with an interest in epilepsy. Physicians were asked how likely was a diagnosis of epilepsy; if seizures were generalised or focal; and the likely etiology. For 23 cases, clinical information was presented in Step 1, and investigations in Step 2. RESULTS 189 Participants from 36 countries completed the 30 cases. Levels of agreement were determined for 154 participants who provided details regarding their clinical experience. There was substantial agreement for diagnosis of epilepsy (kappa=0.61); agreement was fair to moderate for seizure type(s) (kappa=0.40) and etiology (kappa=0.41). For 23 cases with two steps, agreement increased from step 1 to step 2 for diagnosis of epilepsy (kappa 0.56-0.70), seizure type(s) (kappa 0.38-0.52), and etiology (kappa 0.38-0.47). Agreement was better for 53 epileptologists (diagnosis of epilepsy, kappa=0.66) than 56 neurologists with a special interest in epilepsy (kappa=0.58). Levels of agreement differed slightly between physicians practicing in different parts of the world, between child and adult neurologists, and according to one's experience with epilepsy. CONCLUSION Although there is substantial agreement when epileptologists diagnose epilepsy, there is less agreement for diagnoses of seizure types and etiology. Further education of physicians regarding semiology of different seizure types is required. Differences in approach to diagnosis, both between physicians and between countries, could impact negatively on clinical trials of anti-epileptic drugs.
Collapse
Affiliation(s)
- Peter S Bergin
- Department of Neurology, Auckland City Hospital, Grafton, Auckland, New Zealand.
| | - Ettore Beghi
- IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
| | - Lynette G Sadleir
- Department of Paediatrics, University of Otago, Wellington, New Zealand.
| | - Manjari Tripathi
- Department of Neurology, All India Institute of Medical Sciences, New Delhi, India
| | | | - Elisa Bianchi
- IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
| | - Wendyl J D'Souza
- Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Australia.
| | | |
Collapse
|
4
|
Bergin PS, Beghi E, Sadleir LG, Brockington A, Tripathi M, Richardson MP, Bianchi E, Srivastava K, Jayabal J, Legros B, Ossemann M, McGrath N, Verrotti A, Tan HJ, Beretta S, Frith R, Iniesta I, Whitham E, Wanigasinghe J, Ezeala-Adikaibe B, Striano P, Rosemergy I, Walker EB, Alkhidze M, Rodriguez-Leyva I, Ramírez González JA, D'Souza WJ. EpiNet as a way of involving more physicians and patients in epilepsy research: Validation study and accreditation process. Epilepsia Open 2017; 2:20-31. [PMID: 29750210 PMCID: PMC5939455 DOI: 10.1002/epi4.12033] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/22/2016] [Indexed: 11/29/2022] Open
Abstract
Objective EpiNet was established to encourage epilepsy research. EpiNet is used for multicenter cohort studies and investigator‐led trials. Physicians must be accredited to recruit patients into trials. Here, we describe the accreditation process for the EpiNet‐First trials. Methods Physicians with an interest in epilepsy were invited to assess 30 case scenarios to determine the following: whether patients have epilepsy; the nature of the seizures (generalized, focal); and the etiology. Information was presented in two steps for 23 cases. The EpiNet steering committee determined that 21 cases had epilepsy. The steering committee determined by consensus which responses were acceptable for each case. We chose a subset of 18 cases to accredit investigators for the EpiNet‐First trials. We initially focused on 12 cases; to be accredited, investigators could not diagnose epilepsy in any case that the steering committee determined did not have epilepsy. If investigators were not accredited after assessing 12 cases, 6 further cases were considered. When assessing the 18 cases, investigators could be accredited if they diagnosed one of six nonepilepsy patients as having possible epilepsy but could make no other false‐positive errors and could make only one error regarding seizure classification. Results Between December 2013 and December 2014, 189 physicians assessed the 30 cases. Agreement with the steering committee regarding the diagnosis at step 1 ranged from 47% to 100%, and improved when information regarding tests was provided at step 2. One hundred five of the 189 physicians (55%) were accredited for the EpiNet‐First trials. The kappa value for diagnosis of epilepsy across all 30 cases for accredited physicians was 0.70. Significance We have established criteria for accrediting physicians using EpiNet. New investigators can be accredited by assessing 18 case scenarios. We encourage physicians with an interest in epilepsy to become EpiNet‐accredited and to participate in these investigator‐led clinical trials.
Collapse
Affiliation(s)
- Peter S Bergin
- Department of Neurology Auckland City Hospital Auckland New Zealand
| | - Ettore Beghi
- IRCCS-Istituto di Ricerche Farmacologiche Mario Negri Milan Italy
| | - Lynette G Sadleir
- Department of Paediatrics University of Otago Wellington New Zealand
| | | | - Manjari Tripathi
- Department of Neurology All India Institute of Medical Sciences New Delhi India
| | - Mark P Richardson
- Division of Neuroscience King's College London London United Kingdom
| | - Elisa Bianchi
- IRCCS-Istituto di Ricerche Farmacologiche Mario Negri Milan Italy
| | | | | | - Benjamin Legros
- Department of Neurology Université Libre de Bruxelles Brussels Belgium
| | | | - Nicole McGrath
- Department of Medicine Whangarei Hospital Whangarei New Zealand
| | | | | | - Simone Beretta
- Department of Neurology San Gerardo Hospital ASST Monza Italy
| | - Richard Frith
- Department of Neurology Auckland City Hospital Auckland New Zealand
| | - Ivan Iniesta
- Department of Neurology Palmerston North Hospital Palmerston North New Zealand
| | - Emma Whitham
- Flinders Medical Centre and Flinders University Bedford Park South Australia Australia
| | | | | | | | - Ian Rosemergy
- Department of Neurology Wellington Hospital Wellington New Zealand
| | | | - Maia Alkhidze
- Institute of Neurology and Neuropsychology Tbilisi Georgia
| | | | | | - Wendyl J D'Souza
- Department of Medicine St. Vincent's Hospital The University of Melbourne Melbourne Victoria Australia
| | | |
Collapse
|
5
|
Randell RL, Gulati AS, Cook SF, Martin CF, Chen W, Jaeger EL, Schoenborn AA, Basta PV, Dejong H, Luo J, Gallant M, Sandler RS, Long MD, Kappelman MD. Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility Study. JMIR Res Protoc 2016; 5:e3. [PMID: 26732016 PMCID: PMC4719077 DOI: 10.2196/resprot.5171] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2015] [Accepted: 11/01/2015] [Indexed: 12/27/2022] Open
Abstract
Background The Internet has successfully been used for patient-oriented survey research. Internet-based translational research may also be possible. Objective Our aim was to study the feasibility of collecting biospecimens from CCFA Partners, an Internet-based inflammatory bowel disease (IBD) cohort. Methods From August 20, 2013, to January 4, 2014, we randomly sampled 412 participants, plus 179 from a prior validation study, and invited them to contribute a biospecimen. Participants were randomized to type (blood, saliva), incentive (none, US $20, or US $50), and collection method for blood. The first 82 contributors were also invited to contribute stool. We used descriptive statistics and t tests for comparisons. Results Of the 591 participants, 239 (40.4%) indicated interest and 171 (28.9%) contributed a biospecimen. Validation study participants were more likely to contribute than randomly selected participants (44% versus 23%, P<.001). The return rate for saliva was higher than blood collected by mobile phlebotomist and at doctors’ offices (38%, 31%, and 17% respectively, P<.001). For saliva, incentives were associated with higher return rates (43-44% versus 26%, P=.04); 61% contributed stool. Fourteen IBD-associated single nucleotide polymorphisms were genotyped, and risk allele frequencies were comparable to other large IBD populations. Bacterial DNA was successfully extracted from stool samples and was of sufficient quality to permit quantitative polymerase chain reaction for total bacteria. Conclusions Participants are willing to contribute and it is feasible to collect biospecimens from an Internet-based IBD cohort. Home saliva kits yielded the highest return rate, though mobile phlebotomy was also effective. All samples were sufficient for genetic testing. These data support the feasibility of developing a centralized collection of biospecimens from this cohort to facilitate IBD translational studies.
Collapse
Affiliation(s)
- Rachel L Randell
- Department of Pediatrics, Duke University School of Medicine, Duke University, Durham, NC, United States.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Bergin P, Jayabal J, Walker E, Davis S, Jones P, Dalziel S, Yates K, Thornton V, Bennett P, Wilson K, Roberts L, Litchfield R, Te Ao B, Parmer P, Feigin V, Jost J, Beghi E, Rossetti AO. Use of the EpiNet database for observational study of status epilepticus in Auckland, New Zealand. Epilepsy Behav 2015; 49:164-9. [PMID: 25960423 DOI: 10.1016/j.yebeh.2015.04.028] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/10/2015] [Accepted: 04/15/2015] [Indexed: 10/23/2022]
Abstract
The EpiNet project has been established to facilitate investigator-initiated clinical research in epilepsy, to undertake epidemiological studies, and to simultaneously improve the care of patients who have records created within the EpiNet database. The EpiNet database has recently been adapted to collect detailed information regarding status epilepticus. An incidence study is now underway in Auckland, New Zealand in which the incidence of status epilepticus in the greater Auckland area (population: 1.5 million) will be calculated. The form that has been developed for this study can be used in the future to collect information for randomized controlled trials in status epilepticus. This article is part of a Special Issue entitled "Status Epilepticus".
Collapse
Affiliation(s)
- Peter Bergin
- Neurology Department, Auckland City Hospital, Auckland, New Zealand.
| | | | - Elizabeth Walker
- Neurology Department, Auckland City Hospital, Auckland, New Zealand
| | - Suzanne Davis
- Neurology Department, Auckland City Hospital, Auckland, New Zealand
| | - Peter Jones
- Emergency Department, Auckland City Hospital, Auckland, New Zealand
| | - Stuart Dalziel
- Emergency Department, Auckland City Hospital, Auckland, New Zealand
| | - Kim Yates
- Emergency Department, Waitemata District Health Board, Auckland, New Zealand
| | - Vanessa Thornton
- Emergency Department, Middlemore Hospital, Auckland, New Zealand
| | - Patricia Bennett
- Neurology Department, Auckland City Hospital, Auckland, New Zealand
| | - Kaisa Wilson
- Neurology Department, Auckland City Hospital, Auckland, New Zealand
| | - Lynair Roberts
- Neurology Department, Auckland City Hospital, Auckland, New Zealand
| | | | | | | | | | - Jeremy Jost
- Neurology Department, Auckland City Hospital, Auckland, New Zealand; INSERM U1094, Tropical Neuroepidemiology, Limoges, France
| | - Ettore Beghi
- Capo Laboratorio Malattie Neurologiche, Mario Negri Institute, Milan, Italy
| | | |
Collapse
|
7
|
Zeng QY, Fan TT, Zhu P, He RQ, Bao YX, Zheng RY, Xu HQ. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study. PLoS One 2015; 10:e0131566. [PMID: 26147937 PMCID: PMC4493091 DOI: 10.1371/journal.pone.0131566] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2015] [Accepted: 05/12/2015] [Indexed: 11/18/2022] Open
Abstract
Objective To evaluate and compare long-term effectiveness of five antiepileptic drugs (AEDs) for monotherapy of adult patients with focal epilepsy in routine clinical practice. Methods Adult patients with focal epilepsy, who were prescribed with carbamazepine (CBZ), valproate (VPA), lamotrigine (LTG), topiramate (TPM), or oxcarbazepine (OXC) as monotherapy, during the period from January 2004 to June 2012 registered in Wenzhou Epilepsy Follow Up Registry Database (WEFURD), were included in the study. Prospective long-term follow-up was conducted until June 2013. The endpoints were time to treatment failure, time to seizure remission, and time to first seizure. Results This study included 654 patients: CBZ (n=125), VPA (n=151), LTG (n=135), TPM (n=76), and OXC (n=167). The retention rates of CBZ, VPA, LTG, TPM, and OXC at the third year were 36.1%, 32.4%, 57.6%, 37.9%, and 41.8%, respectively. For time to treatment failure, LTG was significantly better than CBZ and VPA (LTG vs. CBZ, hazard ratio, [HR] 0.80 [95% confidence interval: 0.67-0.96], LTG vs. VPA, 0.53 [0.37-0.74]); TPM was worse than LTG (TPM vs. LTG, 1.77 [1.15-2.74]), and OXC was better than VPA (0.86 [0.78-0.96]). After initial target doses, the seizure remission rates of CBZ, VPA, LTG, TPM, and OXC were 63.0%, 77.0%, 83.6%, 67.9%, and 75.3%, respectively. LTG was significantly better than CBZ (1.44 [1.15-1.82]) and OXC (LTG vs. OXC, 0.76 [0.63-0.93]); OXC was less effective than LTG in preventing the first seizure (1.20 [1.02-1.40]). Conclusion LTG was the best, OXC was better than VPA only, while VPA was the worst. The others were equivalent for comparisons between five AEDs regarding the long-term treatment outcomes of monotherapy for adult patients with focal epilepsy in a clinical practice. For selecting AEDs for these patients among the first-line drugs, LTG is an appropriate first choice; others are reservation in the first-line but VPA is not.
Collapse
Affiliation(s)
- Qing-Yi Zeng
- Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, P.R. China
| | - Tian-Tian Fan
- Rehabilitation Center, The First Hospital of Zibo, Zibo, Shandong Province, P.R. China
| | - Pan Zhu
- Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, P.R. China
| | - Ru-Qian He
- Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, P.R. China
| | - Yi-Xin Bao
- Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, P.R. China
| | - Rong-Yuan Zheng
- Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, P.R. China
- * E-mail: (RYZ); (HQX)
| | - Hui-Qin Xu
- Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, P.R. China
- * E-mail: (RYZ); (HQX)
| |
Collapse
|
8
|
McCabe PH. Would Sherlock Holmes agree with our definition of rational polytherapy? A proposal for a national data bank on patients with epilepsy. Epilepsy Behav 2015; 45:147-50. [PMID: 25769675 DOI: 10.1016/j.yebeh.2015.02.010] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/28/2015] [Revised: 02/06/2015] [Accepted: 02/07/2015] [Indexed: 11/18/2022]
Affiliation(s)
- Paul H McCabe
- Neurology, Epilepsy Division, Geisinger Health System, 1800 Mulberry Street, Scranton, PA 18510, USA.
| |
Collapse
|
9
|
Ethical management in the constitution of a European database for leukodystrophies rare diseases. Eur J Paediatr Neurol 2014; 18:597-603. [PMID: 24786336 DOI: 10.1016/j.ejpn.2014.04.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/16/2013] [Revised: 02/17/2014] [Accepted: 04/04/2014] [Indexed: 11/24/2022]
Abstract
BACKGROUND The EU LeukoTreat program aims to connect, enlarge and improve existing national databases for leukodystrophies (LDs) and other genetic diseases affecting the white matter of the brain. Ethical issues have been placed high on the agenda by pairing the participating LD expert research teams with experts in medical ethics and LD patient families and associations. The overarching goal is to apply core ethics principles to specific project needs and ensure patient rights and protection in research addressing the context of these rare diseases. AIM This paper looks at how ethical issues were identified and handled at project management level when setting up an ethics committee. METHODS Through a work performed as a co-construction between health professionals, ethics experts, and patient representatives, we expose the major ethical issues identified. RESULTS The committee acts as the forum for tackling specific issues tied to data sharing and patient participation: the thin line between care and research, the need for a charter establishing the commitments binding health professionals and the information items to be delivered. Ongoing feedback on the database, including delivering global results in a broad-audience format, emerged as a key recommendation. Information should be available to all patients in the partner countries developing the database and should be scaled to different patient profiles. CONCLUSION This work led to a number of recommendations for ensuring transparency and optimizing the partnership between scientists and patients.
Collapse
|
10
|
Liu J, Liu Z, Zhang Z, Dong S, Zhen Z, Man L, Xu R. Internet usage for health information by patients with epilepsy in China. Seizure 2013; 22:787-90. [DOI: 10.1016/j.seizure.2013.06.007] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2013] [Revised: 06/14/2013] [Accepted: 06/15/2013] [Indexed: 10/26/2022] Open
|
11
|
Bergin P. Commentary on “Epilepsy informatics and an ontology-driven infrastructure for large database research and patient care in epilepsy”. Epilepsia 2013; 54:1507-9. [DOI: 10.1111/epi.12239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Peter Bergin
- Department of Neurology; Auckland City Hospital; Auckland New Zealand
| |
Collapse
|